Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apoptosis regulator BAX, also known as BCL2-associated X protein, is a pro-apoptotic member of the BCL-2 family that serves as a critical executioner of the intrinsic cell death pathway (UniProt Q07812). BAX functions as a molecular switch that, upon activation by BH3-only proteins or cellular stress signals, translocates from the cytosol to the mitochondrial outer membrane where it undergoes a major conformational change (Nature, 2008, 455:1076–1081). This process leads to BAX oligomerization and the formation of pores, causing mitochondrial outer membrane permeabilization (MOMP) and the subsequent release of cytochrome c into the cytoplasm to activate caspases (PubMed: 21490342). In many malignancies, BAX is downregulated or inhibited by the overexpression of anti-apoptotic proteins like BCL-2, allowing cancer cells to evade apoptosis and resist chemotherapy (Cancer Cell, 2017, 32:230-244). Therapeutic development has focused on small molecule activators like BTSA1 and BAM7 that directly bind to the BAX trigger site to overcome apoptotic blocks in cancer (Nature Chemical Biology, 2012, 8:366–374). Conversely, inhibiting BAX is explored as a method to prevent pathological cell loss in neurodegenerative diseases and ischemic conditions like myocardial infarction (NIH, PMC: 4507024). While 'Bax mRNA expression' is a common experimental measurement or biomarker used to assess apoptotic potential, the functional therapeutic target is the BAX protein itself.
Small molecule activators bind to the N-terminal trigger site or the BH3-binding groove of BAX, inducing a conformational change that promotes its translocation from the cytosol to the mitochondrial outer membrane, where it oligomerizes to form lethal pores. Inhibitors, such as BAX-inhibiting peptides, work by preventing this translocation or the subsequent oligomerization process to preserve cell viability in degenerative contexts.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apoptosis regulator BAX (BAX) (BAX).